Skip to main content
. 2017 Sep 5;8:193. doi: 10.1186/s13287-017-0644-9

Table 1.

Effect of mesenchymal stem cells on wild-type and CXCR3–/– fibroblast expression of genes encoding extracellular matrix molecules

Gene symbol GenBank™ accession number Common name Fold change + MSC/control (WT) p value Fold change + MSC/control (KO) p value
Fn1 NC_000067 Fibronectin 1 1.91 0.0524 3.21 0.0317
Tnc NC_000070 Tenascin C 1.33 0.0989 2.36 0.0497
Lama1 NC_000083 Laminin, alpha 1 0.89 0.5424 1.34 0.0605
Col3a1 NC_000067 Procollagen, type III, alpha 1 2.67 0.04 2.85 0.035
Actg2 NC_000072 Actin, gamma 2, smooth muscle, enteric 0.25 0.1732 1.77 0.0739
Col4a3 NC_000067 Procollagen, type IV, alpha 3 2.63 0.0352 3.09 0.0204
Mmp9 NC_000068 Matrix metallopeptidase 9 2.41 0.0052 0.88 0.605
Tgfb-1 NC_000073 Transforming growth factor beta-1 0.64 0.1862 0.7 0.1773
Gapdh NC_000072 Glyceraldehyde-3-phosphate dehydrogenase 1.6 0.0089 1.98 0.0056

RNA was extracted from dermal fibroblasts cocultured with MSCs for 36 hours. Gene expression levels were measured. Fold changes in mRNA levels were determined by dividing gene expression levels of fibroblasts cocultured with mesenchymal stem cells by gene expression levels of fibroblasts cocultured with control inserts. Genes in the table demonstrated consistent and statistically significant fold changes (p < 0.05) in response to MSCs. All changes in mRNA levels were statistically significant and reproduced in three independent experiments

KO knock out, MSC mesenchymal stem cell, WT wild type